Eikon Therapeutics Participates in Multiple Investor Conferences

• Eikon Therapeutics CEO Roger M. Perlmutter presents at JP Morgan Biotech Call Series in Boston Nov. 6, 2026, at 2 p.m. EST.
• Perlmutter joins a fireside chat at Guggenheim’s 3rd Annual Healthcare Innovation Conference in Boston Nov. 10, 2026, at 8 p.m. EST.
• Chief Medical Officer Roy Baynes discusses synthetic lethality on Morgan Stanley’s biotech webcast Nov. 3, 2026, at 10:30 a.m. EST.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eikon Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611020915PRIMZONEFULLFEED9867816) on November 02, 2026, and is solely responsible for the information contained therein.